Search by Drug Name or NDC
NDC 59088-0819-03 Lidocaine HCl - Hydrocortisone Acetate 5; 30 mg/g; mg/g Details
Lidocaine HCl - Hydrocortisone Acetate 5; 30 mg/g; mg/g
Lidocaine HCl - Hydrocortisone Acetate is a RECTAL; TOPICAL CREAM in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by PureTek Corporation. The primary component is HYDROCORTISONE ACETATE; LIDOCAINE HYDROCHLORIDE.
MedlinePlus Drug Summary
Rectal hydrocortisone is used along with other medications to treat proctitis (swelling in the rectum) and ulcerative colitis (a condition which causes swelling and sores in the lining of the large intestine and rectum). It is also used to relieve itching and swelling from hemorrhoids and other rectal problems. Hydrocortisone is in a class of medications called corticosteroids. It works by activating natural substances in the skin to reduce swelling, redness, and itching.
Related Packages: 59088-0819-03Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Hydrocortisone Rectal
Product Information
| NDC | 59088-0819 |
|---|---|
| Product ID | 59088-819_f2054b5e-a884-1bd5-e053-2a95a90a015c |
| Associated GPIs | 89991002263720 89991002266420 |
| GCN Sequence Number | 047968 |
| GCN Sequence Number Description | lidocaine/hydrocortisone ac CREAM (G) 3 %-0.5 % TOPICAL |
| HIC3 | T0F |
| HIC3 Description | TOPICAL ANTI-INFLAMMATORY STEROID-LOCAL ANESTHETIC |
| GCN | 13397 |
| HICL Sequence Number | 022142 |
| HICL Sequence Number Description | LIDOCAINE HCL/HYDROCORTISONE ACETATE |
| Brand/Generic | Generic |
| Proprietary Name | Lidocaine HCl - Hydrocortisone Acetate |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Lidocaine HCl and Hydrocortisone Acetate |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | CREAM |
| Route | RECTAL; TOPICAL |
| Active Ingredient Strength | 5; 30 |
| Active Ingredient Units | mg/g; mg/g |
| Substance Name | HYDROCORTISONE ACETATE; LIDOCAINE HYDROCHLORIDE |
| Labeler Name | PureTek Corporation |
| Pharmaceutical Class | Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Local Anesthesia [PE] |
| DEA Schedule | n/a |
| Marketing Category | UNAPPROVED DRUG OTHER |
| Application Number | n/a |
| Listing Certified Through | 2024-12-31 |
Package
NDC 59088-0819-03 (59088081903)
| NDC Package Code | 59088-819-03 |
|---|---|
| Billing NDC | 59088081903 |
| Package | 1 TUBE in 1 CARTON (59088-819-03) / 28.3 g in 1 TUBE |
| Marketing Start Date | 2011-07-01 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 1.42956 |
| Pricing Unit | GM |
| Effective Date | 2023-02-22 |
| NDC Description | LIDOCAINE-HC 3-0.5% CREAM |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 4, 5 |
| Classification for Rate Setting | G |
| As of Date | 2024-02-14 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis